Cash still king for biotech

被引：0

作者：

Wong, JF

机构：

来源：

GENETIC ENGINEERING NEWS | 2003年 / 23卷 / 07期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：41 / +

页数：3

共 50 条

[21] THE BIOTECH SECTORS CLARION CALL FOR CASH
DRAKE, P
BROWN, G
[J]. BIO-TECHNOLOGY, 1995, 13 (01): : 12 - 12
[22] Cash is still necessary
Smiler, S
[J]. FUTURIST, 1999, 33 (08) : 4 - +
[23] Still strapped for cash
Brady Huggett
[J]. Nature Biotechnology, 2009, 27 : 493 - 493
[24] Still strapped for cash
Huggett, Brady
[J]. NATURE BIOTECHNOLOGY, 2009, 27 (06) : 493 - 493
[25] Biotech is still in favour in US
不详
[J]. CHEMISTRY IN BRITAIN, 2001, 37 (07) : 16 - 16
[26] Massachusetts still a biotech heavyweight
Potera, C
[J]. GENETIC ENGINEERING NEWS, 2004, 24 (14): : 18 - +
[27] Are Biotech Inventions Still Protectable?
Jarrell, Brenda Herschbach
Chen, Fangli
[J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (11): : 8 - +
[28] Are biotech inventions still protectable?
Jarrell, Brenda Herschbach
Chen, Fangli
[J]. Genetic Engineering and Biotechnology News, 2010, 30 (11):
[29] British Biotech: Still waiting
Julie Grisham
[J]. Nature Biotechnology, 2000, 18 (3) : 245 - 245
[30] Is cash king? Market performance and cash during a recession
Nason, Robert S.
Patel, Pankaj C.
[J]. JOURNAL OF BUSINESS RESEARCH, 2016, 69 (10) : 4242 - 4248